Answers are grounded in this paper and cite their sources.
Objective Cerebral ischemia-reperfusion (I/R) injury contributes substantially to neuronal damage after stroke. Recent studies have demonstrated the efficacy of Glycyrrhizae radix et rhizoma in I/R injury, yet the underlying mechanism remains unclear. Therefore, the present study investigated whether isoliquiritin apioside (ISLA), a bioactive compound derived from it, protected against cerebral I/R injury. Methods Rats subjected to middle cerebral artery occlusion/reperfusion were treated with ISLA (5, 10, or 20 mg/kg). Neurological outcomes and infarct volume were evaluated, histopathological and apoptotic changes were assessed by H&E and TUNEL staining, oxidative stress was determined by MDA and SOD assays, the expression of proteins related to TXNIP/NLRP3 signaling, pyroptosis, and inflammation was examined by western blotting and immunofluorescence methods. Results ISLA significantly reduced infarct volume, improved neurological function, preserved cortical morphology, and decreased TUNEL-positive cells in the ischemic brain. ISLA also attenuated oxidative stress, as evidenced by reduced MDA levels and restored SOD activity. Mechanistically, ISLA downregulated TXNIP and NLRP3 expressions, suppressed cleaved caspase-1 and cleaved GSDMD production, and reduced IL-1 β and IL-18 levels. Conclusion These findings indicated that ISLA alleviated cerebral I/R injury, at least in part, by reducing oxidative stress and inhibiting TXNIP/NLRP3-associated pyroptotic and inflammatory signaling.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: